Alimera Announces Scientific Data Highlighting ILUVIEN To Be Presented at the American Academy of Ophthalmology
31.10.2023 - ATLANTA, Oct. 31, 2023 (GLOBE NEWSWIRE) - Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining ...
Source: wallstreet-online.de